Does Assaf Itshayek’s Kamada (KMDA) Form 3 show any share purchases or sales?

The Form 3 does not show any share purchases or sales. It only reports existing option holdings, with zero buy and zero sell transactions in the transaction summary, reflecting an initial ownership statement rather than new trading activity.

Kamada director reports option holdings on Form 3

Q: What does Kamada (KMDA) disclose in Assaf Itshayek’s Form 3?

The Form 3 shows director Assaf Itshayek reporting existing holdings of stock options for Kamada’s Ordinary Shares. It details four option positions, each tied to 4,000 underlying shares, establishing his initial derivative ownership as a reporting insider.

Q: How many Kamada (KMDA) shares underlie Assaf Itshayek’s reported options?

Each of the four reported option positions covers 4,000 underlying Ordinary Shares. This means the filing describes option rights over multiple 4,000‑share blocks rather than any immediate share ownership change or open‑market transaction in Kamada’s stock.

Q: What are the exercise terms of Assaf Itshayek’s Kamada (KMDA) stock options?

All reported options have an exercise price of $6.26 per Ordinary Share and expire on March 7, 2030. The filing lists different exercise dates between September 7, 2024 and September 7, 2027, indicating a staged exercisability schedule.

Q: How are Kamada (KMDA) option exercise prices presented in Assaf Itshayek’s Form 3?

The exercise prices are shown in U.S. dollars, translated from New Israeli Shekels. A footnote explains they use the representative exchange rate of the Bank of Israel as of March 13, 2026 for convenience of presentation.

Kamada Ltd. director Assaf Itshayek filed a Form 3 reporting existing holdings of stock options for Ordinary Shares.

Accepted by SEC EDGAR 03/16/2026 - 10:35 AM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Kamada Ltd. director Assaf Itshayek filed a Form 3 reporting existing holdings of stock options for Ordinary Shares. The filing lists four option positions, each covering 4,000 underlying Ordinary Shares at an exercise price of $6.26 per share, expiring on March 7, 2030, with different future exercise dates from September 7, 2024 through September 7, 2027. The options are exercisable using a net-exercise method, and the U.S. dollar exercise prices reflect a convenience translation from New Israeli Shekels based on the Bank of Israel exchange rate as of March 13, 2026.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider ITSHAYEK ASSAF

Role Director

Type	Security	Shares	Price	Value
Holding	Options to purchase Ordinary Shares	--	--	--
Holding	Options to purchase Ordinary Shares	--	--	--
Holding	Options to purchase Ordinary Shares	--	--	--
Holding	Options to purchase Ordinary Shares	--	--	--

Holdings: Options to purchase Ordinary Shares — 16,000 contracts (Direct)

Footnotes (2)

F1. These options to purchase ordinary shares are exercisable using a net-exercise method
F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Kamada (KMDA) disclose in Assaf Itshayek’s Form 3?

The Form 3 shows director Assaf Itshayek reporting existing holdings of stock options for Kamada’s Ordinary Shares. It details four option positions, each tied to 4,000 underlying shares, establishing his initial derivative ownership as a reporting insider.

How many Kamada (KMDA) shares underlie Assaf Itshayek’s reported options?

Each of the four reported option positions covers 4,000 underlying Ordinary Shares. This means the filing describes option rights over multiple 4,000‑share blocks rather than any immediate share ownership change or open‑market transaction in Kamada’s stock.

What are the exercise terms of Assaf Itshayek’s Kamada (KMDA) stock options?

All reported options have an exercise price of $6.26 per Ordinary Share and expire on March 7, 2030. The filing lists different exercise dates between September 7, 2024 and September 7, 2027, indicating a staged exercisability schedule.

How are Kamada (KMDA) option exercise prices presented in Assaf Itshayek’s Form 3?

The exercise prices are shown in U.S. dollars, translated from New Israeli Shekels. A footnote explains they use the representative exchange rate of the Bank of Israel as of March 13, 2026 for convenience of presentation.

What exercise method applies to Assaf Itshayek’s Kamada (KMDA) stock options?

A footnote states these options to purchase ordinary shares are exercisable using a net-exercise method. Under this approach, the holder receives a net number of shares after accounting for the option exercise value instead of paying cash for all shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ITSHAYEK ASSAF

(Last)

(First)

(Middle)

8 HAHAGANA ST

(Street)

KIRYAT ONO

5527807

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to purchase Ordinary Shares⁽¹⁾	09/07/2024	03/07/2030	Ordinary Shares	4,000	$6.26⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	09/07/2025	03/07/2030	Ordinary Shares	4,000	$6.26⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	09/07/2026	03/07/2030	Ordinary Shares	4,000	$6.26⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	09/07/2027	03/07/2030	Ordinary Shares	4,000	$6.26⁽²⁾	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Assaf Itshayek	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR